Continue current treatment: raloxifene

Raloxifene should not be used in women who have or have had any blood clot disorders, including deep vein thrombosis and pulmonary embolism. Based on the recommendation for thromboembolism prophylaxis for 35 days after a hip fracture, a higher risk for fracture patients over 35 days may be expected. Therefore, a drug holiday for 35 days is recommended.

Literature

<%= buttons %>